# US 2012/0231548 A1 · Breath ketone detector

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0231548 A1
- Document ID: US20120231548A1
- Status: Published application
- Kind: A1
- Application number: 13/415,624
- Filed: 2012-03-08
- Published: 2012-09-13
- Earliest claimed: 2011-03-08
- Assignees: Akers Biosciences, Inc.
- Inventors: Raymond F. Akers, JR.
- Web page: https://patentgrep.com/patent/US20120231548A1

## CPC

- G01N 33/52: Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper {and including single- and multilayer analytical elements (immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72)}
- B01L 3/502: {with fluid transport, e.g. in multi-compartment structures}
- G01N 33/1826: {Organic contamination in water}
- G01N 33/6893: {related to diseases not provided for elsewhere}
- B01L 2200/16: Reagents, handling or storing thereof
- B01L 2300/0832: cylindrical, tube shaped
- B01L 2300/0835: Ampoules
- G01N 33/18: Water
- G01N 2800/02: Nutritional disorders
- G01N 2800/18: Dental and oral disorders
- Y10T 436/20: Oxygen containing
- Y10T 436/200833: Carbonyl, ether, aldehyde or ketone containing
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

Ketoacidosis is an extreme and uncontrolled form of ketosis, which is a normal response to prolonged fasting. Embodiments of this invention test the ketone level of a patient by measuring the ketone bodies in breath condensation. Some embodiments include a device for medical testing comprising a hollow container, comprising powder mixture of sodium nitroferricyanide, ammonium sulfate and silica and a liquid including an ammonium hydroxide solution.

## Claims

### Claim 1

A device for medical testing comprising:
a hollow container, comprising:
a powder comprising a powder reagent selected from the group consisting of sodium nitroferricyanide, dinitrophenylhydrazine, copper sulfate/potassium sodium tartrate, and combinations of any thereof; and
a liquid reagent solution.

### Claim 2 (depends on 1)

The device of claim 1, wherein the powder reagent comprises sodium nitroferricyanide.

### Claim 3 (depends on 2)

The device of claim 2, wherein the powder reagent comprises sodium nitroferricyanide in the amount of 0.36 mg to 36 mg.

### Claim 4 (depends on 1)

The device of claim 1, wherein the powder further comprises a first powder component.

### Claim 5 (depends on 4)

The device of claim 4, wherein the first powder component comprises ammonium sulfate.

### Claim 6 (depends on 5)

The device of claim 5, wherein the first powder component comprises ammonium sulfate in the amount of 9.64 mg to 964 mg.

### Claim 7 (depends on 2)

The device of claim 2, wherein the powder reagent further comprises ammonium sulfate in a ratio of nitroferricyanide to ammonium sulfate ranging from 1:15 to 1:26.7.

### Claim 8 (depends on 1)

The device of claim 1, wherein the powder further comprises a second powder component selected from the group consisting of sodium silicate, calcium sulfate, calcium chloride, montmorillonite clay, molecular sieves, phosphorous pentoxide, silica, cellulose, glass beads, poly(2,6-diphenylphenylene oxide polymer and combinations of any thereof.

### Claim 9 (depends on 8)

The device of claim 8, wherein the second powder component comprises 20/50 grade silica.

### Claim 10 (depends on 9)

The device of claim 9, wherein the second powder component comprises 20/50 grade silica in the amount of 10 mg to 1 g.

### Claim 11 (depends on 1)

The device of claim 1, wherein the powder further comprises a third powder component selected from the group consisting of glycine, lactose, disodium hydrogen phosphate, and combinations of any thereof.

### Claim 12 (depends on 1)

The device of claim 1, wherein the liquid reagent solution comprises a strong base.

### Claim 13 (depends on 12)

The device of claim 12, wherein the strong base is selected from the group consisting of an alkali hydroxide, an alkaline-earth metal hydroxide, and combinations of any thereof.

### Claim 14 (depends on 13)

The device of claim 13, wherein the liquid reagent comprises a strong base selected from the group consisting of ammonium hydroxide, lithium hydroxide, sodium hydroxide, potassium hydroxide, rubidium hydroxide, cesium hydroxide, calcium hydroxide, strontium hydroxide, barium hydroxide, and combinations of any thereof.

### Claim 15 (depends on 14)

The device of claim 14, wherein the strong base comprises ammonium hydroxide.

### Claim 16 (depends on 15)

The device of claim 15, wherein the liquid reagent comprises ammonium hydroxide in the amount of 50 μL to 2000 μL of 15% to 30% aqueous solution.

### Claim 17 (depends on 1)

The device of claim 1, wherein the hollow container is a tube.

### Claim 18 (depends on 1)

The device of claim 1, wherein the powder and the liquid reagent solution are contained in glass ampoules.

### Claim 19

A method for testing for the presence of ketones in breath of a patient, comprising:
exposing a powder to the breath of the patient, wherein the powder comprises a reagent selected from the group consisting of sodium nitroferricyanide, dinitrophenylhydrazine, copper sulfate/potassium sodium tartrate, and combinations of any thereof
contacting the powder with a liquid reagent solution to form a combined solution; and
evaluating the color of the combined solution.

### Claim 20 (depends on 19)

The method of claim 19, wherein the powder is contained in a first ampoule, the liquid reagent solution is contained in a second ampoule, and wherein the first and second ampoules are contained within a hollow container.

### Claim 21 (depends on 20)

The method of claim 20, further comprising breaking the first ampoule before exposing the powder to the breath.

### Claim 22 (depends on 21)

The method of claim 21, wherein exposing the powder to the breath comprises the patient blowing into the hollow container.

### Claim 23 (depends on 22)

The method of claim 22, further comprising breaking the second ampoule before contacting the powder with the liquid reagent solution.

### Claim 24 (depends on 19)

The method of claim 19, wherein evaluating the color of the combined solution comprises comparing the color of the combined solution to at least one reference color.

### Claim 25 (depends on 19)

The method of claim 19, wherein the powder comprises sodium nitroferricyanide.

### Claim 26 (depends on 25)

The method of claim 25, wherein the powder further comprises ammonium sulfate and silica.

### Claim 27 (depends on 19)

The method of claim 19, wherein the liquid reagent solution comprises an ammonium hydroxide solution.
